packageEndralazine

endralazine

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Endralazine is a hydrazinophthalazine vasodilator that was developed as an antihypertensive drug to lower blood pressure. It is considered experimental and does not appear to be an approved medicine today, so its current availability is unclear.

Summary written by glm-5.3-flash from Wikidata Q5376588 and the WHO ATC classification; not checked by a person.

name:endralazine
ATC codes:C02DB03
DrugBank:DB13435
PubChem CID:47608
ChEBI:135105
Wikidata:Q5376588
formula:C14H15N5O
molar mass:269.308 g/mol (PubChem CID 47608)
logP:0.4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown